Published in Vaccine Weekly, February 18th, 2004
A spokesman for Wyeth, which co-markets the drug with Gaithersburg-based manufacturer MedImmune Inc., said the move was a goodwill gesture meant to shore up supplies of vaccine during the current shortage of the traditional flu shot.
But some analysts said it was proof of how poor sales of FluMist are, even during one of the worst flu seasons in recent years.
"The fact that they still have doses to give away shows how much things didn't go as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly